# Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients

> **NCT00333021** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 127 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** Fondaparinux sodium
- **DRUG:** GSK576428

## Key facts

- **NCT ID:** NCT00333021
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** 2007-02
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2009-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00333021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00333021, "Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00333021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*